Thrivent Financial for Lutherans
LH icon

Thrivent Financial for Lutherans’s Labcorp LH Stock Holding History

Thrivent Financial for Lutherans’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$187M Buy
701,638
+124,611
+22% +$33.7M 0.36% 44
2025
Q4 		$145M Buy
577,027
+14,021
+2% +$3.72M 0.26% 75
2025
Q3 		$162M Buy
563,006
+45,610
+9% +$12.2M 0.32% 52
2025
Q2 		$136M Buy
517,396
+105,453
+26% +$25.7M 0.3% 63
2025
Q1 		$95.9M Buy
411,943
+8,985
+2% +$2.18M 0.21% 111
2024
Q4 		$92.4M Sell
402,958
-346,310
-46% -$79.4M 0.18% 139
2024
Q3 		$167M Sell
749,268
-73,944
-9% -$16.3M 0.32% 58
2024
Q2 		$168M Sell
823,212
-29,803
-3% -$6.06M 0.34% 51
2024
Q1 		$186M Buy
853,015
+73,853
+9% +$16.3M 0.37% 44
2023
Q4 		$177M Buy
779,162
+821
+0.1% +$172K 0.39% 41
2023
Q3 		$156M Sell
778,341
-55,546
-7% -$11.7M 0.37% 51
2023
Q2 		$173M Buy
833,887
+137,091
+20% +$26.6M 0.39% 41
2023
Q1 		$137M Sell
696,796
-23,593
-3% -$4.85M 0.33% 60
2022
Q4 		$146M Sell
720,389
-237,389
-25% -$46.4M 0.38% 50
2022
Q3 		$169M Sell
957,778
-84,506
-8% -$17.3M 0.46% 27
2022
Q2 		$210M Buy
1,042,284
+1,016,688
+3,972% +$217M 0.56% 17
2022
Q1 		$5.8M Buy
25,596
+1,211
+5% +$285K 0.01% 839
2021
Q4 		$6.58M Sell
24,385
-777
-3% -$192K 0.01% 807
2021
Q3 		$6.08M Sell
25,162
-139
-0.5% -$35K 0.01% 829
2021
Q2 		$6M Buy
25,301
+29
+0.1% +$6.61K 0.01% 849
2021
Q1 		$5.54M Sell
25,272
-1,036
-4% -$208K 0.01% 874
2020
Q4 		$4.6M Sell
26,308
-13,947
-35% -$2.41M 0.01% 893
2020
Q3 		$6.51M Sell
40,255
-2,798
-6% -$443K 0.02% 717
2020
Q2 		$6.14M Buy
43,053
+80
+0.2% +$11.1K 0.02% 670
2020
Q1 		$4.67M Sell
42,973
-3,657
-8% -$527K 0.02% 676
2019
Q4 		$6.78M Buy
46,630
+23,888
+105% +$3.45M 0.02% 662
2019
Q3 		$3.28M Buy
22,742
+867
+4% +$127K 0.01% 788
2019
Q2 		$3.25M Buy
21,875
+16,670
+320% +$2.33M 0.01% 801
2019
Q1 		$684K Buy
5,205
+1
+0% +$123 ﹤0.01% 1620
2018
Q4 		$565K Buy
5,204
+91
+2% +$12.2K ﹤0.01% 1498
2018
Q3 		$763K Sell
5,113
-350
-6% -$53.2K ﹤0.01% 1450
2018
Q2 		$843K Sell
5,463
-16,660
-75% -$2.51M ﹤0.01% 1371
2018
Q1 		$3.07M Buy
22,123
+1,362
+7% +$200K 0.01% 764
2017
Q4 		$2.85M Buy
20,761
+80
+0.4% +$10.6K 0.01% 793
2017
Q3 		$2.68M Buy
20,681
+15,792
+323% +$2.11M 0.01% 777
2017
Q2 		$647K Buy
4,889
+512
+12% +$62.7K ﹤0.01% 1365
2017
Q1 		$539K Sell
4,377
-4,423
-50% -$524K ﹤0.01% 1489
2016
Q4 		$971K Buy
8,800
+245
+3% +$27.2K ﹤0.01% 1172
2016
Q3 		$1.01M Buy
8,555
+1,303
+18% +$154K ﹤0.01% 1124
2016
Q2 		$812K Sell
7,252
-6,239
-46% -$671K ﹤0.01% 1192
2016
Q1 		$1.36M Sell
13,491
-22,896
-63% -$2.2M 0.01% 983
2015
Q4 		$3.87M Sell
36,387
-131
-0.4% -$13.5K 0.02% 667
2015
Q3 		$3.4M Buy
36,518
+33,492
+1,107% +$3.46M 0.02% 663
2015
Q2 		$315K Buy
3,026
+116
+4% +$12.1K ﹤0.01% 1370
2015
Q1 		$315K Buy
2,910
+582
+25% +$59.9K ﹤0.01% 1354
2014
Q4 		$216K Hold
2,328
– – ﹤0.01% 1560
2014
Q3 		$204K Hold
2,328
– – ﹤0.01% 1586
2014
Q2 		$205K Sell
2,328
-58
-2% -$5.02K ﹤0.01% 1622
2014
Q1 		$201K Buy
+2,386
New +$190K ﹤0.01% 1473
2013
Q4 		– Sell
-91,424
Closed -$7.79M – 1590
2013
Q3 		$7.79M Sell
91,424
-1,397
-2% -$118K 0.05% 353
2013
Q2 		$7.98K Buy
+92,821
New +$7.71M 0.05% 354

Other funds holding LH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Thrivent Financial for Lutherans's LH Position: Q1 2026 in Review

Thrivent Financial for Lutherans increased its Labcorp (LH) stake by 22% in Q1 2026, buying an estimated $33.7M and bringing the position to 701,638 shares worth $187M. The position accounts for 0.36% of the portfolio, ranked #44.

Thrivent Financial for Lutherans first reported a position in LH in Q2 2013 and has held it in 51 quarters since. The position peaked at $210M in Q2 2022. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Thrivent Financial for Lutherans held 701,638 shares of Labcorp worth $187M as of Q1 2026.
  • Thrivent Financial for Lutherans bought 124,611 Labcorp shares in Q1 2026, an estimated $33.7M.
  • Labcorp made up 0.36% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #44 holding.
  • Thrivent Financial for Lutherans first reported a position in Labcorp in Q2 2013 and has held it in 51 quarters since.
  • Thrivent Financial for Lutherans's Labcorp position peaked at $210M in Q2 2022.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.